...
首页> 外文期刊>Traffic >Structure and function of the Lowe syndrome protein OCRL1
【24h】

Structure and function of the Lowe syndrome protein OCRL1

机译:Lowe综合征蛋白OCRL1的结构和功能

获取原文
获取原文并翻译 | 示例
           

摘要

Oculocerebrorenal syndrome of Lowe (OCRL) is an X-linked disorder with the hallmark features of congenital cataracts, mental retardation and Fanconi syndrome of the kidney proximal tubules. OCRL was first described in 1952, and exactly four decades later, the gene responsible was identified and found to encode a protein highly homologous to inositol polyphosphate 5-phosphatase. This suggested that Lowe syndrome may represent an inborn error of inositol phosphate metabolism, and subsequent studies confirmed that such metabolism is indeed perturbed in Lowe syndrome cells. However, the mechanism by which loss of function of the OCRL1 protein brings about Lowe syndrome remains ill defined. In this review, I will discuss our understanding of OCRL1, including where it is localized, what it interacts with and what its possible functions might be. I will then discuss possible mechanisms by which loss of OCRL1 may bring about cellular defects that manifest themselves in the pathology of Lowe syndrome.
机译:Lowe的眼脑肾综合征(OCRL)是一种X连锁疾病,具有先天性白内障,智力低下和肾近端小管Fanconi综合征的特征。 OCRL于1952年首次被描述,正好在四十年后,鉴定了负责的基因并发现其编码与肌醇多磷酸5磷酸酶高度同源的蛋白质。这表明Lowe综合征可能代表了肌醇磷酸代谢的先天性错误,随后的研究证实,这种代谢确实在Lowe综合征细胞中受到干扰。但是,OCRL1蛋白功能丧失导致Lowe综合征的机制仍然不清楚。在这篇评论中,我将讨论我们对OCRL1的理解,包括其本地化,与之交互以及可能的功能。然后,我将讨论OCRL1缺失可能导致在Lowe综合征病理中表现出来的细胞缺陷的可能机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号